The capability of p16 as an HCC biomarker has been reported in the previous literature, Zhang et al. and Koziol et al. reported p16 as a member of the TAA microarrays and it has great performance in the early diagnosis of HCC [18,38]. The gene discussed is CDKN2A; the disease is hepatocellular carcinoma.